NANORISK
DEAD

Serial Number

77255521

Owner

nanoLife Sciences, Inc.

Attorney

Tamsen V. Valoir

Filing Date

Aug 15, 2007

Add to watchlist:

No watchlists yet
View on USPTO

NANORISK Trademark

Serial Number: 77255521

NANORISK is a trademark filed by nanoLife Sciences, Inc. on August 15, 2007. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

nanoLife Sciences, Inc. (3 trademarks)

P.O. Box 1548
Austin, TX 787671548

Entity Type: 03

Trademark Details

Filing Date

August 15, 2007

Registration Date

Not Registered

Published for Opposition

September 2, 2008

Goods & Services

Teaching, training and educational services, namely, classes, seminars, workshops in the field of risk assessment of nanomaterials, nanodevices and toxicology

Software programs and downloadable software programs for use in risk assessment of nanomaterials, nanodevices and toxicology; scientific apparatus, instruments and devices for research and examination purposes, namely, lab-on-a-chip devices comprising microfluidics for use in the identification or assessment of nanoscale materials or biological interactions with nanoscale materials; gene microarrays comprising of oligo nucleotides for use in the identification or assessment of nanoscale materials or biological interactions with nanoscale materials; biosensors using chemical, electrochemical, biochemical, enzymatic, chromatographic, spectroscopic, or mass spectral detection methods for use in the identification or assessment of nanoscale materials or biological interactions with nanoscale materials; computers programmed with relational or expert databases of nanoscale material identification or assessment information for use in identification or assessment of nanoscale materials or biological interactions with nanoscale materials; laboratory equipment, measuring apparatus and instruments, namely, nanoscale material generation systems for introduction of nanoscale materials into physical, chemical, biochemical, or biological test systems comprised of dust generators for generating in vitro and in vivo exposures to nanoparticulates for inhalation exposures at toxicologic, pharmacologic, or therapeutic airborne concentrations, vaporizers, nebulizers and sprayers all for use in generating in vitro and in vivo exposures to droplets and other particles containing nanomaterials for inhalation exposures at toxicologic, pharmacologic or therapeutic concentrations, mixers for preparing test materials in solution, semi-solids or solids for exposures or doses of nanomaterials in vitro or in vivo experimental tests of a biological or clinical nature, incubators for creating and maintaining controlled test environments; pipettors, disposable syringes and containers and containment devices designed to retain, and deliver nanomaterials in liquid, semi-solid or solid dosage forms and for chemical analysis of dosage forms and biological samples from toxicologic or pharmacologic exposures in vitro and in vivo, and microplates designed to contain nanomaterials to avoid physicochemical, chemical, physical or electromagnetic effects that would interfere with precise measurements of toxicologic or pharmacologic endpoints; photometric test systems for use in the identification or assessment of nanoscale materials comprised of microplate readers, photomicroscopes, uv/vis photometers and photometric detectors, infrared photometers, photometric detectors, x-ray, gamma-ray, photo fluorescence and magnetic resonance imaging equipment; environmental sampling devices or systems for use in the identification or assessment of nanoscale materials or biological interactions with nanoscale materials comprised of dust and particulate impact collectors, electrostatic precipitators, water filtration collectors, centrifugal collection devices, air filtration devices and collectors, size exclusion separators, mass spectrometric air sampling systems comprised of mass selective or multiple detectors; photometric air and water sampling systems comprised of air or water sampling chambers with infrared, visible, ultraviolet, fluorescent or laser photometric means of nanoparticulate detection, x-ray diffraction and x-ray fluorescence sampling systems comprised of a variable x-ray source, nanomaterials containment or targeting device and an x-ray detector, liquid and chromatographic sampling systems comprised of an electronically or hydraulically controlled liquid sampling loop to deliver nanomaterials and a microprocessor-controlled microplate or vial in rack-type sample collector; all of the above goods are intended for scientific and laboratory research purposes and not medical purposes

Biological diagnostic preparations for medical analysis use; chemical preparations for medical use, namely, chelators and scavengers for removing or diagnosing toxic nanoparticles; diagnostic preparations for medical use

Biological preparations for scientific research purposes, namely, biological tissues or cell lines for use in the identification or assessment of nanoscale materials or biological interactions with nanoscale materials; proteins, peptide substrates, or enzymes for use in the identification or assessment of nanoscale materials or biological interactions with nanoscale materials; chemical test kits containing biological tissues, cell lines, proteins, peptide substrates, or enzymes for use in the identification or assessment of nanoscale materials or biological interactions with nanoscale materials; chemical preparations for scientific analysis purposes, namely, reagents for use in the identification or assessment of nanoscale materials or biological interactions with nanoscale materials; test kits containing chemical reagents for non-medical purposes, namely, for use in the identification or assessment of nanoscale materials or biological interactions with nanoscale materials; chemical preparations for scientific purposes, namely, chemical formulations for the solubilization, stabilization, or activation of nanoscale materials for use in presentation of nanoscale materials to various biological, physical, or chemical test systems to facilitate identification or assessment of nanoscale materials or biological interactions with nanoscale materials; diagnostic preparations for scientific use

Scientific research and development for others in the fields of life sciences, biotechnology, toxicology, and genomics; chemical and toxicological analysis service; computer services, namely, providing online databases and websites featuring reports in the field of risk assessment of nanomaterials, nanodevices and toxicology

Filing History

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 22, 2010 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 22, 2010 REAP
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Jun 28, 2010 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 28, 2010 ABN6
SOU EXTENSION 2 GRANTED
Jan 28, 2010 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 13, 2010 AITU
SOU EXTENSION 2 FILED
Nov 23, 2009 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 23, 2009 EEXT
SOU EXTENSION 1 GRANTED
May 25, 2009 EX1G
SOU EXTENSION 1 FILED
May 25, 2009 EXT1
SOU TEAS EXTENSION RECEIVED
May 25, 2009 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Nov 25, 2008 NOAM
PUBLISHED FOR OPPOSITION
Sep 2, 2008 PUBO
NOTICE OF PUBLICATION
Aug 13, 2008 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 28, 2008 PREV
EXAMINERS AMENDMENT MAILED
Jul 24, 2008 CNEA
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 24, 2008 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 24, 2008 XAEC
EXAMINERS AMENDMENT -WRITTEN
Jul 24, 2008 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jul 1, 2008 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jun 27, 2008 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 18, 2008 PREV
ASSIGNED TO LIE
Jun 18, 2008 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 18, 2008 CNSA
EXAMINERS AMENDMENT MAILED
Jun 16, 2008 CNEA
EXAMINER'S AMENDMENT ENTERED
Jun 13, 2008 XAEC
EXAMINERS AMENDMENT -WRITTEN
Jun 13, 2008 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 19, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 19, 2008 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 19, 2008 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 20, 2008 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 20, 2008 REAP
NON-FINAL ACTION MAILED
Nov 26, 2007 CNRT
NON-FINAL ACTION WRITTEN
Nov 24, 2007 CNRT
ASSIGNED TO EXAMINER
Nov 23, 2007 DOCK
NEW APPLICATION ENTERED
Aug 20, 2007 NWAP